ImmunityBio Inc (NASDAQ: IBRX) is -5.47% lower on its value in year-to-date trading and has touched a low of $2.50 and a high of $10.53 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The IBRX stock was last observed hovering at around $2.56 in the last trading session, with the day’s loss setting it -0.14%.
Currently trading at $2.42, the stock is -11.60% and -41.52% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 6.33 million and changing -5.47% at the moment leaves the stock -52.08% off its SMA200. IBRX registered -42.92% loss for a year compared to 6-month loss of -63.88%. The firm has a 50-day simple moving average (SMA 50) of $4.1384 and a 200-day simple moving average (SMA200) of $5.049675.
The stock witnessed a -49.58% gain in the last 1 month and extending the period to 3 months gives it a -27.11%, and is -5.84% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 8.05% over the week and 8.15% over the month.
ImmunityBio Inc (IBRX) has around 628 employees, a market worth around $1.77B and $7.33M in sales. Profit margin for the company is -8016.83%. Distance from 52-week low is -3.20% and -77.02% from its 52-week high. The company has generated returns on investments over the last 12 months (-222.32%).
with sales reaching $7.51M over the same period.The EPS is expected to grow by 30.00% this year, but quarterly earnings will post 3,310.93% year-over-year. Quarterly sales are estimated to grow 5,303.24% in year-over-year returns.
ImmunityBio Inc (IBRX) Top Institutional Holders
252.0 institutions hold shares in ImmunityBio Inc (IBRX), with institutional investors hold 36.28% of the company’s shares. The shares outstanding are 696.83M, and float is at 75.93M with Short Float at 65.86%. Institutions hold 9.62% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 13.83 million shares valued at $87.42 million. The investor’s holdings represent 2.0558% of the IBRX Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 11.42 million shares valued at $72.19 million to account for 1.6978 of the shares outstanding. The other top investors are STATE STREET CORP which holds 7.86 million shares representing 1.1688% and valued at over $49.7 million, while GEODE CAPITAL MANAGEMENT, LLC holds 0.5822 of the shares totaling 3.92 million with a market value of $24.76 million.
ImmunityBio Inc (IBRX) Insider Activity
#####
